1[1]Ridker PM ,Vaughan DE ,Stampfer MJ,et al.Endogenous tissue-type plasminogen activator and risk of myocardial infarction[J].Lancet,1993,341(8854):1165-1168.
2[2]Ridker PM,Hennekens CH,Stampfer MJ,et al.Prospective study of endogenous tissue plasminogen activator and risk of stroke[J].Lancet,1994,343(8903):940-943.
4[4]Lupu F,Bergonzelli GE,Heim DA,et al.Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries [J].Arterioscler Thromb,1993,13(7):1090-1100.
5[5]Lindgren A,Lindoff C,Norrving B,et al.Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients[J].Stroke,1996,27(6):1066-1071.
6[6]Cote R,Wolfson C,Solymoss S,et al.Hemostatic markers in patients at risk of cerebral ischemia[J].Stroke ,2000,31(8):1856-1862.
7[7]Tohgi H,Kawashima M,Tamura K,et at.Coagulation-fibrinolysis abnormalities in acute and chronic phases of cerebral thrombosis and embolism[J].Stroke ,1990,21(12):1663-1667.
8[9]Feinberg WM,Bruck DC,Ring ME,et al.Hemostatic markers in acute stroke[J].Stroke,1989,20(5):592-597.
9[10]Feinberg WM,Erickson LP,Bruck D,et al.Hemostatic markers in acute ischemic stroke:association with stroke type ,severity,and outcome [J].Stroke,1996,27(8):1296-1300.
10[11]Ageno W,Finazzi S,Steidl L,et al.Plasma measurement of D-dimer levels for the early diagnosis of ischemic stroke subtypes [J].Arch Intern Med,2002,162(22):2589-2593.
